A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies
NCT00787033
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
PF-04554878
Sponsor
Verastem, Inc.